Adhansia XR from Adlon Therapeutics is a long-acting central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD) in children aged 6 and older.
Adlon recently announced that in a clinical trial, ADHD patients had a significant improvement in symptoms starting after one hour after taking the drug and up to 16 hours.
Adlon recently won approval for a supplemental New Drug Application to include supplementary clinical data in adult patients with ADHD.
Filed Under: Neurological Disease
Tell Us What You Think!
You must be logged in to post a comment.